INVESTOR PROFILE

Jeffrey Leiden

Jeffrey Leiden

Jeffrey Leiden

USA

Jeffrey Leiden is a physician and scientist of more than 40 years, who is currently the executive chairman of US-based multinational biotech company Vertex Pharmaceuticals.  Leiden is also the chairman of Casana, a remote healthcare platform and the chairman of Tmunity, a biotech dedicated to T-cell research. In March 2021, he participated as an angel investor in the $48m Series A round of Dutch cell-based meat startup Meatable which leverages pluripotent stem cells for the first time in foodtech. 

Limited Reading

The rest of the content is only available if you are logged in.

Limited Reading
LOG IN
RECOMMENDED
Rabobank

Investor

Rabobank

Netherlands

Repsol Foundation

Investor

Repsol Foundation

Spain

K2 Global

Investor

K2 Global

USA

RECOMMENDED

Rabobank

Investors

Rabobank

Netherlands

Repsol Foundation

Investors

Repsol Foundation

Spain

K2 Global

Investors

K2 Global

USA

Your payment was not successful.

Please make sure you have entered your payment details correctly. Or try again in a few moments.

small logo

The discount code you entered is invalid

Please make sure you have entered your discount code correctly. Or try again in a few moments.

Download successful.

Your sample has been sent. Please check your email.

By accessing and using www.compasslist.com and all pages within the domain (the “Website”), You accept and agree to have read, understood, accepted and agreed to be bound by the Terms of Use and Privacy Policy in full. If you disagree with all or any part of these Terms of Use and Privacy Policy, please do not use or continue any further use of this website. You acknowledge that you are aware that this Website contains an archive of existing content as at 31 December 2021 and is not being actively managed. We are under no obligation to update the content on this Website and, accordingly, no new content or articles will be posted to the Website after 31 December 2021.